|
注册号: Registration number: |
ChiCTR2200066608 |
|
最近更新日期: Date of Last Refreshed on: |
2023-08-20 21:47:51 |
|
注册时间: Date of Registration: |
2022-12-12 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
儿童青少年超重肥胖干预 |
|
Public title: |
Intervention for children and adolescents with overweight or obesity |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
强化生活方式对儿童青少年超重肥胖的干预效果研究 |
|
Scientific title: |
Research on the effect of lifestyle enhancement intervention on overweight and obesity in children and adolescents |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
赵栋 |
研究负责人: |
赵栋 |
|
Applicant: |
Dong Zhao |
Study leader: |
Dong Zhao |
|
申请注册联系人电话: Applicant telephone: |
+86 159 5801 4972 |
研究负责人电话:
Study leader's |
+86 159 5801 4972 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
dzhao@cdc.zj.cn |
研究负责人电子邮件: Study leader's E-mail: |
dzhao@cdc.zj.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
浙江省杭州市滨江区滨盛路3399号 |
研究负责人通讯地址: |
浙江省杭州市滨江区滨盛路3399号 |
|
Applicant address: |
3399 Binsheng Road, Binjiang District, Hangzhou, Zhejiang |
Study leader's address: |
3399 Binsheng Road, Binjiang District, Hangzhou, Zhejiang |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
浙江省疾病预防控制中心 |
||
|
Applicant's institution: |
Zhejiang Provincial Center for Disease Control and Prevention |
||
|
研究负责人所在单位: |
浙江省疾病预防控制中心 |
||
|
Affiliation of the Leader: |
Zhejiang Provincial Center for Disease Control and Prevention |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2022-045-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
浙江省疾病预防控制中心伦理审查委员会 |
||
|
Name of the ethic committee: |
Ethics Review Committee of Zhejiang Provincial Center for Disease Control and Prevention |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-11-23 00:00:00 | ||
|
伦理委员会联系人: |
吴晓丽 |
||
|
Contact Name of the ethic committee: |
Xiaoli Wu |
||
|
伦理委员会联系地址: |
浙江省杭州市滨江区信诚路630号 |
||
|
Contact Address of the ethic committee: |
630 Xincheng Road , Binjiang District, Hangzhou, Zhejiang |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
浙江省疾病预防控制中心 |
||||||||||||||||||||||
|
Primary sponsor: |
Zhejiang Provincial Center for Disease Control and Prevention |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
浙江省杭州市滨江区信诚路630号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
630 Xincheng Road, Binjiang District, Hangzhou, Zhejiang |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
浙江省卫生健康委(NO.2022RC123) |
||||||||||||||||||||||
|
Source(s) of funding: |
Zhejiang Provincial Health Commission (NO.2022RC123) |
||||||||||||||||||||||
|
研究疾病: |
超重和肥胖 |
||||||||||||||||||||||
|
Target disease: |
Overweight and obesity |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
整群随机分组 |
||||||||||||||||||||||
|
Study design: |
Cluster randomization |
||||||||||||||||||||||
|
研究目的: |
1.通过整群随机对照试验评估强化生活方式干预对青春期超重肥胖儿童BMI、腰围、血压、血糖、血脂等肥胖相关指标的改善效果。 2.摸索出防控青春期儿童超重肥胖的适宜技术。 3.为进一步科学的遏制儿童青少年超重肥胖提供科学方法。 |
||||||||||||||||||||||
|
Objectives of Study: |
1. To evaluate the impact of intensive lifestyle interventions on obesity-related indicators such as BMI, waist circumference, blood pressure, blood glucose, and lipids in overweight and obese adolescent children based on the cluster-randomized controlled trial. 2. To find appropriate techniques to prevent and control overweight and obesity in adolescent children. 3. To provide scientific methods to further reduce overweight and obesity in children and adolescents. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1. 身体有重大疾病者; 2. 不能参与运动干预者; 3. 其他不能参与研究或影响依从性的情况。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. People with serious diseases; 2. Those who cannot participate in sports intervention; 3. Other conditions that prevent participation in the study or affect compliance. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-12-06 00:00:00至 To 2022-12-11 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-12-12 00:00:00 至 To 2022-12-16 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
平湖疾控中心人员,随机数字表法,以学校为单位整群随机分为干预组和对照组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Pinghu CDC staff use the random number table method to divide the whole group into the intervention and control arms, taking the school as the unit. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
暂不共享 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
NOT shared |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
将由接受过培训的调查人员采集所有数据。实行双人双录入的方式进行数据的录入和核查工作。研究人员定期对上报的双录入电子版数据库进行检查和逻辑核查,并将核查报告和修改后的数据库加密保存至指定计算机留档。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
All data will be collected by trained investigators. Double entry method will be used for data input and verification. Study investigators will regularly check and verify the electronic database. Also, they will encrypt the verification report and the finalized database to the designated computer for archives. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |